LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
28.57
+0.14 (0.49%)
Nov 5, 2024, 3:49 PM EST - Market open
LENZ Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
785.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 15.00M | - | - |
| Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLENZ News
- 8 days ago - LENZ Therapeutics' Investigational Drug For Age-Related Blindness Aces Pivotal China Trial, Analyst Says Data Readout May Strengthen Position For Ex-U.S. Partnerships - Benzinga
- 8 days ago - CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100 - GlobeNewsWire
- 15 days ago - LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia - GlobeNewsWire
- 21 days ago - Lucy Therapeutics Appoints Kim Drapkin as Board Chair - Business Wire
- 2 months ago - LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks - Seeking Alpha
- 2 months ago - LENZ Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - LENZ Therapeutics, Inc. (LENZ) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - LENZ Therapeutics Reports Second Quarter 2024 Financial Results - GlobeNewsWire